Skip to main content
Publications
Fuller CC, Kawai AT , Haynes K, Coughlin K, Reynolds JS, Hawrusik R, Horgan C, Calingaert B , Johannes CB , Bradley Layton J , Peterson A, Praet N, Willame C, Yost E, Brannan C, McMahill-Walraven CNN, Guzman M, Jamal-allial A, Nair V, Seals RM, Wang FT, Selvan M, Ma Q, Platt R, Gilsenan AW , Brown J. Capacity for identifying Janssen Ad26.COV2.S COVID-19 vaccination in four US health insurance and state Immunization Information System databases: preparation for a post authorization safety study . Presented at the 2022 ICPE Conference; August 2022. Copenhagen, Denmark.
Johannes C , Layton JB , Beachler DM, Ziemiecki RM , Li L, Danysh HE , Dinh J, Hunt PR, Karlsson C, Chen H, Gilsenan A . Risk of acute kidney injury in real-world use of dapagliflozin . Presented at the 2021 Virtual American Diabetes Association 81st Scientific Session; June 25, 2021.
Myers RP, Brogan AJ , Talbird SE , Thompson J, Marcellin P, Jacobson IM, DeMasi R, Menzie AM, Yoshida EM. Efficacy, safety, and cost-effectiveness in Canada of telaprevir combination therapy by baseline fibrosis stage in treatment-naïve patients with chronic genotype 1 hepatitis C virus infection . Presented at the 2013 Canadian Digestive Diseases Week and the Annual Winter Meeting of the Canadian Association for the Study of the Liver; March 2013.